Trending...
- Cybersecurity is THE Hot Market Sector; Revenues, Earnings & Profit matter; Only 33 Million Shares + a Huge Short Position Equal an Undervalued Stock
- The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
- Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT
FAYETTEVILLE, Ark. - nvtip -- Lineus Medical continues to expand the patent protection of its flagship product, SafeBreak Vascular, a break-away medical device technology that helps protect IV lines. The company was awarded United States utility patent US10655768B2 that covers several key features of the device. This is the third patent awarded to Lineus Medical, which now has two utility patents and one design patent pertaining to SafeBreak Vascular.
SafeBreak Vascular is a first of its kind breakaway medical device designed for peripheral IV lines. When a damaging level of force is applied to an IV line, SafeBreak Vascular purposefully separates to minimize the effects of the damaging force and to prevent patient bleeding and the spillage of medication. Vance Clement, CEO of Lineus Medical said, "This issuance of this new utility patent is another important step in adding value to our company and protecting our first product to market, SafeBreak Vascular. The portfolio of patents the company has secured puts the company in a strong intellectual property position to protect and defend its value and SafeBreak Vascular from competition."
More on nvtip.com
Spencer Jones, Chief Technology Officer and Founder of Lineus Medical commented, "We continue to build an intellectual property moat around SafeBreak Vascular, and that moat just became more difficult to overcome. Innovation in product design must be accompanied by meaningful patent protection, and we expect that our issued patents and patents currently under review will further protect our technologies and set-us apart for many years in the market place."
ABOUT LINEUS MEDICAL
Lineus Medical is a developer of medical device technologies that serve the vascular access/IV market. The company develops products that help prevent pain and discomfort in patients, save nurses time and control costs for hospitals. SafeBreak Vascular is not yet FDA cleared and is not yet for sale. More information about Lineus Medical is available at www.lineusmed.com.
MKG-0068 Rev 00
SafeBreak Vascular is a first of its kind breakaway medical device designed for peripheral IV lines. When a damaging level of force is applied to an IV line, SafeBreak Vascular purposefully separates to minimize the effects of the damaging force and to prevent patient bleeding and the spillage of medication. Vance Clement, CEO of Lineus Medical said, "This issuance of this new utility patent is another important step in adding value to our company and protecting our first product to market, SafeBreak Vascular. The portfolio of patents the company has secured puts the company in a strong intellectual property position to protect and defend its value and SafeBreak Vascular from competition."
More on nvtip.com
- Dr. Aubrey de Grey Brings Cutting-Edge Science to RAADfest 2025: LEV Foundation Partners with Coalition for Radical Life Extension
- $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
- Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild
Spencer Jones, Chief Technology Officer and Founder of Lineus Medical commented, "We continue to build an intellectual property moat around SafeBreak Vascular, and that moat just became more difficult to overcome. Innovation in product design must be accompanied by meaningful patent protection, and we expect that our issued patents and patents currently under review will further protect our technologies and set-us apart for many years in the market place."
ABOUT LINEUS MEDICAL
Lineus Medical is a developer of medical device technologies that serve the vascular access/IV market. The company develops products that help prevent pain and discomfort in patients, save nurses time and control costs for hospitals. SafeBreak Vascular is not yet FDA cleared and is not yet for sale. More information about Lineus Medical is available at www.lineusmed.com.
MKG-0068 Rev 00
Source: Lineus Medical
0 Comments
Latest on nvtip.com
- Drone Light Shows Emerge as the New Standard in Live Event Entertainment
- Lore Link is Here to Help Organize Your Game
- Chappaqua's Annual Townwide Summer Sale – Unbeatable Savings at Your Favorite Local Boutiques!
- Inside the Mind of an Investor: What They Look for in a Business Plan
- Skyline Partners with ZenSpace to Offer Private Meeting Pods for Trade Show Exhibitors
- AI Innovation Dual-Strategy Business Model Focused on Real Estate Development for Strategic Expansion: OFA Group, (N A S D A Q: OFAL)
- Construcción del Corredor Norte–Sur (NSC) de Singapur
- New Report: Slip and Fall Accidents Rank as the Leading Cause of Construction Site Fatalities
- Get Your Cowboy Boots On! Causeway Country BBQ Music Festival Kicks Off September 12–14 in Ft. Pierce
- Retired Hobbyist Launches Bold Weekly Album Project Using AI Songwriting Tools
- DimHum Launches Revolutionary CrowdShipping Service
- Eolian Signs New Information Exchange Agreement with the U.S. Department of Defense for Technology Innovation
- Infinite Health Introduces Cutting-Edge Regenerative Medicine for Wound Care with Trip Goolsby, MD
- Top Dentist Concord CA, Smile Makers Dental Care, Celebrates 500 5-Star Reviews
- Bio-Inspired Technology-Dynamic and Adaptable for unknown real-world environments
- Michael Reafsnyder opens solo exhibition at Scott Richards Contemporary Art in San Francisco
- Valley Sleep Therapy Expands to Prescott with New Location at Crossings Road
- $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
- $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
- Pacsun Joins UFC International Fight Week with Exclusive Collection and First-Ever UFC X Activation